Disseminated histoplasmosis in children: The role of itraconazole therapy

Pediatric Infectious Disease Journal

Volumn 15, Issue 11, 1996, Pages 1002-1008

  Tobón, Angela M ^a   Franco, Lilliana ^a   Espinal, David ^b   Gómez, Ivan ^a   Arango, Myrtha ^a   Trujillo, Hugo ^b   Restrepo, Angela ^a  

^a Corporación para Investigaciones Biológicas ^*  (Colombia)

^b HOSPITAL PABLO TOBÓN URIBE   (Colombia)

Author keywords

childhood histoplasmosis; diagnosis; Disseminated histoplasmosis; itraconazole therapy; posttherapy follow up

Indexed keywords

ITRACONAZOLE;

ADOLESCENT; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FEVER; HEPATOMEGALY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; MALE; PRIORITY JOURNAL; SPLENOMEGALY; WEIGHT REDUCTION;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HISTOPLASMOSIS; HUMANS; INFANT; ITRACONAZOLE; MALE; TREATMENT OUTCOME;

EID: 0029828509     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199611000-00014     Document Type: Article

References (21)

1. Leissa B, Wiedermann BL. Histoplasmosis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd ed. Philadelphia: Saunders, 1992:1952-64.
2. Sathapatayavongs B, Batteiger BE, Wheat LJ, Slama TG, Wass JL. Clinical and laboratory features of disseminated histoplasmosis during a large urban outbreak. Medicine 1983;62:263-70.
3. Wheat LJ. Histoplasmosis: recognition and treatment. Clin Infect Dis 1994;19(Suppl. 1):S19-27.
4. Goodwin RA Jr, Shapiro JL, Thurman GH, Thurman SS, des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine 1980;59:1-33.
5. Leggiadro RJ, Barret RF, Hugnes WT. Disseminated histoplasmosis of infancy. Pediatr Infect Dis J 1988;7:799-805.
6. Hughes WT. Hematogenous histoplasmosis in the immunocompromised child. J Pediatr 1984;105:569-75.
7. Little J, Bruce J, Andrews H, Crawford K, McKinley G. Treatment of disseminated infantile histoplasmosis with amphotericin B. Pediatrics 1959;24:1-6.
8. Wheat LJ, Hafner R, Korzum AH, Limjoco MT, Spencer P, Larsen R. Itraconazole treatment of disseminated histoplasmosis in AIDs patients. Am J Med 1995;98:336-42.
9. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330:263-72.
10. Negroni R, Robles AM, Arechavala A, Taborda A. Itraconazole in human histoplasmosis. Mycoses 1988;32:123-30.
11. Wheat LJ, Hafner RE, Ritchie M, Schneider D. Itraconazole is effective treatment for histoplasmosis in AIDS: prospective multicenter noncomparative trial [Abstr. 1206]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11 to 14, 1992. Washington, DC: American Society for Microbiology, 1992.
12. Panamerican Sanitary Bureau. Coordinating Committee for the Mycoses. Subcommittee of Diagnostic Procedures. Manual of standardized serodiagnostic procedures for systemic mycoses: part I. Agar immunodiffusion test. Washington, DC: Panamerican Sanitary Bureau, 1972:363-81.
13. Panamerican Sanitary Bureau, Coordinating Committee for the Mycoses. Subcommittee of Diagnostic Procedures. Manual of standardized serodiagnostic procedures for systemic mycoses: Part II. Complement fixation test. Washington, DC: Panamerican Sanitary Bureau, 1972:135-40.
14. Schafer M. Pharmacokinetic optimisation of oral antifungal therapy. Clin Pharmacokinet 1993;25:329-41.
15. Restrepo A, Gómez I, Cano LE, et al. Treatment of paracoccidioidomycosis with ketoconazole: a three year experience. Am J Med 1983;24:48-52.
16. Gordon E, Schutze GE, Hickeson SL, et al. Blastomycosis in children. Clin Infect Dis 1996;22:496-502.
17. Furcolow ML. Course and prognosis of untreated histoplasmosis. JAMA 1961;177:292-6.
18. Furcolow ML. Comparison of treated and untreated severe histoplasmosis. JAMA 1963;183:121-7.
19. Dismukes WE, Cloud G, Bowles C, et al. Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial. Ann Intern Med 1985;103:861-72.
20. Kaufman CA. Newer developments in therapy for endemic mycoses. Clin Infect Dis 1994;19(Suppl. 1):S28-32.
21. Díaz S, Tabares AM, De Bedout C, Restepo A. Esporotricosis en niños [AbstractC-28.293]. Presented at the VII Congreso Panamericano de Infectología. VI Congreso Latinoamericano de Infectología Pediátrica. II Congreso Colombiano de Infectología, Cartagena, Colombia, May 28 to 31, 1995:90.